U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07080242) titled 'Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors' on July 14.
Brief Summary: The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Tumors
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Small-cell Lung Cancer
Neuroendocrine Cancer
Prostate Cancer
Gastrointestinal Neuroendocrine Tumor
Merkel Cell Carcinoma, Recurrent
Intervention:
DRUG: BL-M14D1
BL-M14D1 will be administered on D1 every 3 wee...